SYNERGY announced that the company recently received the drug registration certificate for Mesilate Potassium issued by the South Korean Ministry of Food and Drug Safety. The manufacturer's name is Jiangxi SYNERGY Pharmaceutical Co., Ltd., and the manufacturer's address is Jiangxi Province, Fengxin High-tech Industrial Park. The certification scope is for Mesilate Potassium active pharmaceutical ingredient, with the certificate number 2025-A1-0844, issued on 2025.04.14. Mesilate Potassium is suitable for the treatment of adult primary hypertension. The company's Mesilate Potassium product obtaining the drug registration certificate in South Korea marks that the company's Mesilate Potassium active pharmaceutical ingredient has gained access to the South Korean market, which will play a positive role in further expanding the company's international market business
